SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations (India) informs about un-audited financial results

18 Feb 2019 Evaluate

Syncom Formulations (India) has informed about submission of Press Clipping related to extract of Standalone Un-Audited Financial Results for the Quarter/ Nine Months ended on 31st December, 2018.

The above information is a part of company's filings submitted to BSE.

Syncom Formulations Share Price

13.99 -0.35 (-2.44%)
20-Apr-2026 11:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.90
Dr. Reddys Lab 1237.60
Cipla 1237.10
Zydus Lifesciences 941.00
Lupin 2328.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×